Purchase Order 75F40123P00130
Award Date 8/2/23
Potential Completion Date 8/1/24
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Jefferson, AR 72079, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Caitta Inc. was awarded a $1.14 million firm-fixed-price purchase order by the Department of Health and Human Services' Food and Drug Administration to deliver a high-resolution mass spectrometer coupled with liquid chromatography system. The contract calls for Caitta to provide one LC-HRMS system to the FDA's St. Louis facility to support research projects involving small molecule pharmaceutical impurity analysis and extractable and leachable characterization. The base period runs from...
- Caitta Inc. was awarded a firm-fixed price purchase order totaling $627,786.88 by the Department of Health and Human Services' Food and Drug Administration to deliver one benchtop quadrupole-orbital trapping high-resolution mass spectrometer with liquid chromatograph. This award was made under a small business set-aside total small business solicitation seeking this type of analytical instrumentation to support research and development of qualitative and semi-quantitative methods for emerging...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB). The contract, valued at $711,271.48, is for the procurement of one Sciex Triple Quadrupole 7500 QTRAP mass spectrometer and preventative maintenance services for a base year and four 1-year option periods. This award was made under a total small business set-aside for the original solicitation, which sought...
- The U.S. Food and Drug Administration (FDA) awarded a $704,138.55 firm-fixed-price purchase order to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB), for the procurement of an ultra-high sensitivity, liquid chromatography-hybrid triple quadrupole-linear accelerator trap mass spectrometer (LC-MS/MS) system. This purchase order is set aside for small businesses and has a completion date of September 19, 2027. Caitta Inc. is an experienced federal...
- This is a $535,268.72 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The contract is for the delivery of a quadrupole-orbitrap high resolution mass spectrometer with liquid chromatograph. This specialized scientific instrumentation will support the FDA's analytical and regulatory missions. The contract has an ultimate completion date of October 17, 2026 and...
- The Department of Health and Human Services Food and Drug Administration awarded a $217,346.52 firm fixed price purchase order to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The award is for contractor support services, with a performance period ending on May 3, 2023. Caitta has a history of providing scientific, technical, and administrative services to HHS and its agencies, including the FDA, NIH, and NIST, through both competitive awards and...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The $1,092,204.46 contract is for the delivery of two mass spectrometers, with a completion date of September 22, 2027. Caitta Inc. is a strategic federal contractor focused on providing scientific instrumentation, analytical equipment, and professional services to...
- The U.S. Food and Drug Administration (FDA) awarded a $1,516,025.52 firm fixed-price purchase order contract to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB), to provide a Liquid Chromatography Coupled with High Resolution-Accurate Mass Tandem Mass Spectrometer System (LC-HRAM-MS/MS). This contract has a completion date of November 19, 2024 and was set aside for small businesses. Caitta Inc. is an experienced provider of scientific instrumentation...
- The Department of Health and Human Services Food and Drug Administration awarded Caitta Inc., an SBA Certified 8A Program Participant, a $183,561 firm fixed price delivery order to provide a portable thermal desorption-ambient ionization-mass detector system. The order was awarded on February 24, 2022 with a completion date of February 27, 2023. No set-aside designation was applied. Caitta Inc. will deliver the requested portable mass spectrometer to the FDA's Miami, Florida location to...
- Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business, was awarded a $61,358.50 firm fixed price purchase order by the Department of Health and Human Services' Food and Drug Administration (FDA) to deliver a FAST 4DX Autosampler/Autodilution System. This total small business set-aside contract supports the FDA's mission and is associated with Solicitation 75F40123Q00473, which requested this automated sampling and dilution system. Caitta holds multiple...
Caitta Inc., doing business as Caitta Inc., has been awarded a $25,499.98 firm fixed-price purchase order by the Department of Health and Human Services' Food and Drug Administration to provide preventive maintenance and legacy software support for an AB Sciex Q-trap 5500 mass spectrometer system and associated subcomponents located in Jefferson, Arkansas. The one-year contract, set aside for total small business, will cover the period from August 2, 2023 through August 1, 2024. No major subcontractors were identified. The award will facilitate the FDA's continued use of mass spectrometry technology in its regulatory science and public health programs through ensuring proper upkeep and support of existing capital equipment.
Generated 12/22/23, 1:29 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.5k | 8/2/23 |